Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
In addition to Macquarie, ALS also received a Buy from Bell Potter’s Joseph House in a report issued today. However, on May 11, Jarden maintained a Sell rating on ALS (Other OTC: CPBLF).
Based on ALS’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of A$1.66 billion and a net profit of A$177 million. In comparison, last year the company earned a revenue of A$1.54 billion and had a net profit of A$129.4 million
